A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q
Clinical trial NCT01029262 · COMPLETED
Trial details
- NCT number
- NCT01029262
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-26
- Primary completion
- 2013-03-17
- Enrollment
- 239
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.